Codexis (CDXS) Restructuring Costs (2022 - 2023)

Codexis (CDXS) posted Restructuring Costs of $3.1 million for Q3 2023, up 4261.11% on a QoQ basis from $72000.0 in Q2 2023.

Analysis

Codexis (CDXS) Restructuring Costs (2022 - 2023) Analysis & Trends

Codexis has reported Restructuring Costs for 2 years, with the latest figure at $3.1 million in Q3 2023.

On a quarterly basis, Restructuring Costs changed N/A year-over-year to $3.1 million in Q3 2023; TTM through Jun 2024 was $3.1 million, a 5.16% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, changed N/A from the prior year.
Restructuring Costs was $3.1 million for Q3 2023 at Codexis, up from $72000.0 in the prior quarter.
The five-year high for Restructuring Costs was $3.2 million in Q4 2022, with the low at $72000.0 in Q1 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	226.93 Bn	222.99 Bn	8.34 Bn
2	Danaher	145.94 Bn	141.60 Bn	3.61 Bn
3	Agilent Technologies	42.55 Bn	40.79 Bn	1.04 Bn
4	Illumina	32.95 Bn	31.78 Bn	770.00 Mn
5	Revvity	14.53 Bn	13.51 Bn	416.87 Mn
6	Bio-Techne	11.31 Bn	11.04 Bn	211.39 Mn
7	Bio-Rad Laboratories	10.34 Bn	8.72 Bn	345.80 Mn
8	Repligen	9.46 Bn	8.44 Bn	110.04 Mn
9	Bruker	8.91 Bn	8.73 Bn	416.00 Mn
10	Codexis	133.43 Mn	78.51 Mn	11.40 Mn

Historic Data

Download Data